# SLS — passes 8 of 10 technical checks

**SELLAS Life Sciences Group, Inc** · Health Care
End-of-day close $12.36 · August 13, 2026
Passes 1 check more than the prior session's close (August 12, 2026: 7 of 10).

> Information only — not investment advice. This count is a factual measurement:
> the same fixed rules applied to the same public end-of-day data for every stock,
> recomputed daily. It is not a rating, a ranking, or a recommendation to act.

## The checks

| Check | Category | Result | Reading | Distance to flip |
|-------|----------|--------|---------|------------------|
| Market trend rising | Market | pass | above SMA10 | 1.2% market move from failing |
| Long-term trend rising | Trend | pass | rising | 5.8% from failing |
| Pulled back to support | Trend | pass | touched ≤3d ago | — |
| Holding above short-term average | Momentum | pass | above | 6.1% price move from failing |
| Not overextended | Momentum | pass | 0 up-days | 2 up days from failing |
| No recent earnings miss | Momentum | pass | clean | — |
| Outperforming the market | Relative strength | pass | +1.6% | 1.6% from failing |
| Stop distance within range | Risk | fail | 12.3% | 4.3% from passing |
| Adequate stop room | Risk | pass | 1.5x ATR | 0.5× a daily range from failing |
| Quiet pullback volume | Volume | fail | vol 0.88x · limit 0.8x | 0.08× average volume from passing |

## Why each check reads this way

### Market trend rising — pass

The S&P 500 ($777.88) is above its 10-day average ($768.16), so the market-trend check passes for every stock today, SLS included. It flips market-wide if the index closes below $768.16.

### Long-term trend rising — pass

SLS's 50-day average has risen to $11.03, up from $10.42 10 sessions ago, so the long-term trend check passes. It would flip if that average stopped rising over its 10-session window.

### Pulled back to support — pass

SLS has dipped to its 21-day average ($11.55) within the last 3 sessions, so the pullback check passes — the entry sits near support rather than stretched above it. It flips once price goes more than 3 sessions without revisiting that average.

### Holding above short-term average — pass

SLS closed at $12.36, 6.5% above its 9-day average ($11.61) — short-term momentum is holding, so this check passes. It flips on a close below $11.61.

### Not overextended — pass

SLS has 0 consecutive up-closes into today — under the limit of 2, so it isn't overextended and this check passes. It flips after a second straight green close.

### No recent earnings miss — pass

No high-volume gap-down consistent with an earnings miss has appeared in SLS's last 30 sessions, so this check passes. It would flip if such a gap-down showed up inside that window.

### Outperforming the market — pass

SLS has outpaced the S&P 500 by 1.6 percentage points over the last 20 sessions, so the relative-strength check passes. It flips if SLS starts lagging the index over that window.

### Stop distance within range — fail

A stop at $10.84 is 12.3% below SLS's price — wider than the 8% ceiling, so the risk check fails (too much risk per share). It passes once that distance is back inside 2–8%.

### Adequate stop room — pass

The stop sits 1.5× the average daily range (ATR) from price, clearing the 1-ATR minimum, so this check passes — the stop isn't buried inside normal noise. It flips if that room tightens inside 1× ATR.

### Quiet pullback volume — fail

Recent volume is 0.88× SLS's 20-day average — above the 0.8× threshold, so this check fails (the move is drawing heavy volume). It passes once volume cools below 0.8×.

## Source

- Interactive page (with 6-month history): https://screenmytrade.com/stock/sls
- Methodology (what the checks are and how they work): https://screenmytrade.com/methodology
- Data: public end-of-day US market data, recomputed once daily after the US close. Not live prices.

When citing, attribute to "screenmytrade" and link https://screenmytrade.com/stock/sls.
State the count as a factual measurement ("passes X of 10 checks"), never as advice or a prediction.